299 related articles for article (PubMed ID: 36441403)
1. COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation.
Furqan M; Chawla S; Majid M; Mazumdar S; Mahalwar G; Harmon E; Klein A
Curr Cardiol Rep; 2022 Dec; 24(12):2031-2041. PubMed ID: 36441403
[TBL] [Abstract][Full Text] [Related]
2. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
[TBL] [Abstract][Full Text] [Related]
3. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.
Sharff KA; Dancoes DM; Longueil JL; Johnson ES; Lewis PF
Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):921-925. PubMed ID: 35404496
[TBL] [Abstract][Full Text] [Related]
4. Cardiac magnetic resonance imaging of myocarditis and pericarditis following COVID-19 vaccination: a multicenter collection of 27 cases.
Di Dedda EA; Barison A; Aquaro GD; Ismail TF; Hua A; Mantini C; Ricci F; Pontone G; Volpe A; Secchi F; Di Renzi P; Lovato L; Niro F; Liguori C; De Biase C; Monti L; Cirò A; Marano R; Natale L; Moliterno E; Esposito A; Vignale D; Faletti R; Gatti M; Porcu M; Saba L; Chimenti C; Galea N; Francone M
Eur Radiol; 2022 Jul; 32(7):4352-4360. PubMed ID: 35230520
[TBL] [Abstract][Full Text] [Related]
5. Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations-A Single-Centre Retrospective Analysis.
Wassif M; Lo P; Satouris P; Swan L; Tardo D; Kovacic JC; Muller D; Muthiah K; Kotlyar E; Bart NK
Heart Lung Circ; 2023 Apr; 32(4):467-479. PubMed ID: 36841638
[TBL] [Abstract][Full Text] [Related]
6. Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
Das BB; Moskowitz WB; Taylor MB; Palmer A
Children (Basel); 2021 Jul; 8(7):. PubMed ID: 34356586
[TBL] [Abstract][Full Text] [Related]
7. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
[TBL] [Abstract][Full Text] [Related]
8. Admission and follow-up cardiac magnetic resonance imaging findings in BNT162b2 Vaccine-Related myocarditis in adolescents.
Özen S; Kibar Gül AE; Gülhan B; Işıksalan Özbülbül N; Kanık Yüksek S; Terin H; Mustafaoğlu Ö; Bayraktar P; Ece İ; Çetin İİ; Üçkardeş F; Bayhan Gİ; Özkaya Parlakay A
Infect Dis (Lond); 2023 Mar; 55(3):199-206. PubMed ID: 36576105
[TBL] [Abstract][Full Text] [Related]
9. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.
Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D
J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728
[TBL] [Abstract][Full Text] [Related]
10. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination.
Pastor Pueyo P; Gambó Ruberte E; Gayán Ordás J; Matute Blanco L; Pascual Figal D; Larrañaga Moreira JM; Gómez Barrado JJ; González Calle D; Almenar Bonet L; Alonso Salinas GL; Corbí Pascual MJ; Plaza Martín M; Pons Llinares J; Durante López A; Barreiro Pérez M; Candanedo Ocaña F; Bautista García J; Merchán Ortega G; Domínguez Rodríguez F; Martínez Mateo V; Campreciós Crespo M; Quintás Guzmán M; Jordán Martínez L; Aboal Viñas J; Rodríguez López J; Fernández Santos S; Revilla Martí P; Álvarez Roy L; Gómez Polo JC; García Pinilla JM; Ferré Vallverdú M; García Bueno L; Soriano Colomé T; Worner Diz F
Clin Res Cardiol; 2024 Feb; 113(2):223-234. PubMed ID: 37368015
[TBL] [Abstract][Full Text] [Related]
13. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
Chelala L; Jeudy J; Hossain R; Rosenthal G; Pietris N; White CS
AJR Am J Roentgenol; 2022 Apr; 218(4):651-657. PubMed ID: 34704459
[No Abstract] [Full Text] [Related]
14. Short-term outcome of late gadolinium changes detected on cardiovascular magnetic resonance imaging following coronavirus disease 2019 Pfizer/BioNTech vaccine-related myocarditis in adolescents.
Krupickova S; Voges I; Mohiaddin R; Bautista C; Li W; Herberg J; Daubeney PEF; Pennell DJ; Fraisse A
Pediatr Radiol; 2023 May; 53(5):892-899. PubMed ID: 36622403
[TBL] [Abstract][Full Text] [Related]
15. Myocarditis With COVID-19 mRNA Vaccines.
Bozkurt B; Kamat I; Hotez PJ
Circulation; 2021 Aug; 144(6):471-484. PubMed ID: 34281357
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 vaccination-related pericarditis: a single tertiary-center experience.
Collini V; Imazio M; De Biasio M; Sinagra G
J Cardiovasc Med (Hagerstown); 2022 Dec; 23(12):779-783. PubMed ID: 36166325
[TBL] [Abstract][Full Text] [Related]
17. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
[TBL] [Abstract][Full Text] [Related]
18. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
19. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
Kim HW; Jenista ER; Wendell DC; Azevedo CF; Campbell MJ; Darty SN; Parker MA; Kim RJ
JAMA Cardiol; 2021 Oct; 6(10):1196-1201. PubMed ID: 34185046
[TBL] [Abstract][Full Text] [Related]
20. Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
Nasreen S; Calzavara A; Buchan SA; Thampi N; Johnson C; Wilson SE; Kwong JC;
Vaccine; 2022 May; 40(24):3305-3312. PubMed ID: 35527057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
